Oyewale Tomori

Oyewale Tomori (born 3 February 1946, Osun State, Nigeria) is a Nigerian professor of virology, educational administrator, and former vice chancellor of Redeemer's University.[1][2][3][4] In 2024, he became the chair of West Africa National Academy of Scientists. [5]

Oyewale Tomori
President of the Nigerian Academy of Science 2013
Vice chancellor of Redeemer's University
In office
2004–2011
Personal details
Born (1946-02-03) 3 February 1946 (age 78)
Osun State, Nigeria
Political partyNon-Partisan

Life and career

Tomori was born in Ilesa, Osun State, Nigeria on 3 February 1946. He received a Doctor of Veterinary Medicine(DVM) from Ahmadu Bello University, Zaria as well as a Doctorate degree, Ph.D in virology from the University of Ibadan, Oyo State, Nigeria where he was appointed professor of virology in 1981, the same year he received the United States Department of Health and Human Services Public Health Service Certificate for contributions to Lassa Fever Research.[6][7][8] Three years (1984) after his appointment as a professor of virology, he was appointed the head of the Department of Virology. At the University of Ibadan Tomori's research interest focuses on viral infections including Ebola hemorrhagic fever,[9] yellow fever, Lassa fever.[10] He served as the Regional Virologist for the World Health Organization Africa Region (1994-2004) before he was appointed as the pioneer vice chancellor of Redeemer's University, Ogun State, Nigeria, a tenure that ended in 2011.[11][12] [13]

Other activities

Awards and fellowships

He is a recipient of several awards and fellow of many international academic organizations. Among others are;

Selected works

  • The reemergence of Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995 [18]
  • Yellow fever: a decade of reemergence[19]
  • Review of cases of nosocomial Lassa fever in Nigeria: the high price of poor medical practice [20]
  • The revised global yellow fever risk map and recommendations for vaccination, 2010: consensus of the Informal WHO Working Group on Geographic Risk for Yellow [21]
  • Monoclonal antibodies to lymphocytic choriomeningitis and pichinde viruses: generation, characterization, and cross-reactivity with other arenaviruses [22]

Others

  • Yellow fever: the recurring plague [23]
  • Randomised controlled trials for Ebola: practical and ethical issues [24]
  • Risk factors for Marburg hemorrhagic fever, Democratic Republic of the Congo [25]
  • Transmission dynamics and control of Ebola virus disease outbreak in Nigeria, July to September 2014 [26]
  • Multiple independent emergences of type 2 vaccine-derived polioviruses during a large outbreak in northern Nigeria [27]
  • Viral hemorrhagic fever antibodies in Nigerian populations [28]
  • Yellow fever vaccination and pregnancy: a four-year prospective study
  • Urban yellow fever epidemic in western Nigeria, 1987 [29]
  • The global virome project [30]
  • Recovery of a Lassa-related arenavirus in Zimbabwe [31]
  • Toward a common secure future: four global commissions in the wake of Ebola [32]
  • Genomic analysis of Lassa virus during an increase in cases in Nigeria in 2018 [33]
  • Impact of yellow fever on the developing world [34]
  • Monoclonal antibodies to lymphocytic choriomeningitis virus react with pathogenic arenaviruses [35]
  • Global incidence of serogroup B invasive meningococcal disease: a systematic review [36]

See also

References